ThePrint on MSN
Roche patent case: Why SC refused to halt Natco’s generic spinal muscular atrophy drug Risdiplam
Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with ...
Viking Therapeutics recently initiated a Phase 1 clinical trial to evaluate various maintenance dosing regimens of VK2735, its dual GLP-1/GIP agonist, in adults with obesity after reporting positive ...
AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, ...
Many drug developers rely on spray-dried dispersions (SDDs) for early-phase development of poorly soluble compounds. While this approach offers speed and regulatory familiarity, it often leads to ...
A £5 bet on what would happen to Axel Rudakubana was reportedly offered at a meeting of professionals who were discussing his care five ...
Bhopal: The main accused in the deadly cough syrup case and owner of Tamil Nadu-based Sresan Pharmaceuticals, Dr. G.
In an effort to tackle the global crisis of road traffic collisions, the United Nations Institute for Training and Research ...
The U.S. Supreme Court on Monday declined to take up an appeal by Purdue Pharmaceuticals after the now-bankrupt drugmaker lost a bid to block a generic version of the painkiller OxyContin.
Discover why Bristol-Myers Squibb (BMY) is a strong buy in 2024—undervalued, high dividend, and robust strategies for ...
A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results